Lung: Non Small Cell Regimens

DISEASE: Lung: Non Small Cell

Select a REGIMEN:

CAMP
CAP
CBDCA+VP-16
CDDP + VP-16
FED
MVP
NVB[Navelbine(R)]-30
NVB[Navelbine(R)]-15
NVB-30+CDDP
NVB-15+CDDP
PVP-16
VIP(ICE)-2

DISEASE: Lung: Non Small Cell

REGIMEN: CAMP

CYCLOPHOSPHAMIDE

DOXORUBICIN [DOX] 20 mg/m2 IV...D1,8
Caution: Monitor cumulative dose (cardiac toxicity)

METHOTREXATE [MTX] 15 mg/m2 IV...D1,8

PROCARBAZINE [PCB] 100 mg/m2 per day PO...D1-10

CYCLE: 28 days
REFER: Bitran JD, et al: CANCER TREAT REP 1976; 60:1225-1230.

DISEASE: Lung: Non Small Cell

REGIMEN: CAP

CYCLOPHOSPHAMIDE

DOXORUBICIN [DOX] 40 mg/m2 IV...D1
Caution: Monitor cumulative dose (cardiac toxicity)

CISPLATIN [CDDP] 60 mg/m2 IV...D1

CYCLE: 28 days
REFER: Eagan RT, et al: CANCER TREAT REP 1979; 63:1589-1591.

DISEASE: Lung: Non Small Cell

REGIMEN: CBDCA+VP-16

CARBOPLATIN

ETOPOSIDE [VP-16] 100 mg/m2 per day IV...D1-3

CYCLE: 28 days
REFER: Klastersky JP: J CLIN ONCOL 1990; 8:1556-1562.

DISEASE: Lung: Non Small Cell

REGIMEN: CDDP + VP-16

CISPLATIN

ETOPOSIDE [VP-16] 120 mg/m2 IV...D4,6,8 "or D3,5,7"

CYCLE: 21-28 days
REFER: Longeval E, et al: CANCER 1982; 50:2751-2756.

DISEASE: Lung: Non Small Cell

REGIMEN: FED

CISPLATIN

ETOPOSIDE [VP-16] 80 mg/m2 per day IV...D2,3,4

FLUOROURACIL [5-FU] 960 mg/m2 per day x 3 CIV...D2,3,4
(2880 mg/m2 total)

CYCLE: 3 weeks
REFER: Sridhar KS, et al: SEMIN IN SURG ONCOL 1993; 9:114-119.

DISEASE: Lung: Non Small Cell

REGIMEN: MVP

MITOMYCIN C

VINBLASTINE [VLB] 6 mg/m2 IV...D1

CISPLATIN [CDDP] 40 mg/m2 IV...D1

CYCLE: 21 days
REFER: Bonomi PD, et al: J CLIN ONCOL 1989; 7:1602-1613.

DISEASE: Lung: Non Small Cell

REGIMEN: NVB[Navelbine(R)]-30

VINORELBINE

CYCLE: None
REFER: LeChevalier T, et al: J CLIN ONCOL 1994; 12:360-367.

DISEASE: Lung: Non Small Cell

REGIMEN: NVB[Navelbine(R)]-15

VINORELBINE

CYCLE: None
REFER: LeChevalier T, et al: J CLIN ONCOL 1994; 12:360-367..

DISEASE: Lung: Non Small Cell

REGIMEN: NVB-30+CDDP

VINORELBINE

CISPLATIN [CDDP] 120 mg/m2 IV...D1,29 then q6wks

CYCLE: None
REFER: LeChevalier T, et al: J CLIN ONCOL 1994; 12:360-367..

DISEASE: Lung: Non Small Cell

REGIMEN: NVB-15+CDDP

VINORELBINE

CISPLATIN [CDDP] 120 mg/m2 IV...D1,29 then q6wks

CYCLE: None
REFER: LeChevalier T, et al: J CLIN ONCOL 1994; 12:360-367..

DISEASE: Lung: Non Small Cell

REGIMEN: PVP-16

CISPLATIN

ETOPOSIDE [VP-16] 50 - 120 mg/m2 per day IV...D1-3

CYCLE: 21-28 days
REFER: Klastersky J: SEMIN IN ONCOL 1986; 13(Suppl 3):104-114.

DISEASE: Lung: Non Small Cell

REGIMEN: VIP(ICE)-2

IFOSFAMIDE

CISPLATIN [CDDP] 100 mg/m2 IV...D1,8

ETOPOSIDE [VP-16] 60 - 75 mg/m2 per day IV...D1-3

CYCLE: 28 days
REFER: Perez EA, et al: PROC ASCO 1992; 11:314.

Medicine OnLine and UltiTech have no liability for content or goods on the Internet except as set forth in the Terms and Conditions of service.

=Please read the Disclaimer of Warranties before using information contained in this section.

© Copyright 1995-2009 UltiTech, Inc. All Rights Reserved.

[ Top Of Page | Regimens Index | DoseCalc Index ]